MARKET

FBIO

FBIO

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.890
+0.110
+6.18%
After Hours: 1.910 +0.02 +1.06% 16:35 03/31 EDT
OPEN
1.800
PREV CLOSE
1.780
HIGH
1.900
LOW
1.760
VOLUME
212.94K
TURNOVER
--
52 WEEK HIGH
3.110
52 WEEK LOW
1.040
MARKET CAP
148.29M
P/E (TTM)
-2.6767
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average FBIO stock price target is 9.20 with a high estimate of 19.00 and a low estimate of 4.000.

EPS

FBIO News

More
  • Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
  • GlobeNewswire · 1d ago
  • Fortress Biotech Announces Up to $5 Million Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
  • GlobeNewswire · 03/23 14:20
  • Analysts Are Upgrading Fortress Biotech, Inc. After Its Latest Results
  • Simply Wall St. · 03/18 11:39
  • Fortress Biotech EPS misses by $0.01, beats on revenue
  • seekingalpha · 03/17 02:13

Industry

Pharmaceuticals
-0.13%
Pharmaceuticals & Medical Research
-0.17%

Hot Stocks

Symbol
Price
%Change

About FBIO

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers kinds of Fortress Biotech Inc stock information, including NASDAQ:FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions.